Literature DB >> 1332065

Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.

A L Gashler1, D T Bonthron, S L Madden, F J Rauscher, T Collins, V P Sukhatme.   

Abstract

Wilms tumor, an embryonic kidney malignancy, accounts for approximately 6% of all pediatric neoplasms. A gene implicated in the genesis of this tumor, the Wilms tumor suppressor gene (WT1), encodes a zinc-finger DNA-binding protein (WT1) that functions as a transcriptional repressor. In certain Wilms tumors, the platelet-derived growth factor A chain (PDGF-A) is overexpressed; it has therefore been suggested that it may play an autocrine role in development of these neoplasms. Since the PDGF-A promoter contains putative binding sites for WT1, we explored the role of WT1 in regulating A-chain expression. The major PDGF-A promoter activity was localized in transient transfection assays to a region spanning from -643 to + 8 relative to the transcription start site. WT1 bound to several sites in this region of the promoter, as demonstrated by gel-shift analysis and DNase I footprinting, and functioned as a powerful repressor of PDGF-A transcription in vivo. Maximal repression (> 50-fold) of the PDGF-A promoter was dependent on the presence of multiple WT1 binding sites in transient transfection assays. Our observations suggest a mechanism for normal downregulation of a growth factor gene and of an autocrine growth process of import in kidney development and other biological systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332065      PMCID: PMC50467          DOI: 10.1073/pnas.89.22.10984

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.

Authors:  F J Rauscher; J F Morris; O E Tournay; D M Cook; T Curran
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

2.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides.

Authors:  J E De Larco; G J Tadaro
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

Review 4.  Signal transduction by the platelet-derived growth factor receptor.

Authors:  L T Williams
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

5.  Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.

Authors:  G E Fraizer; D F Bowen-Pope; A M Vogel
Journal:  J Cell Physiol       Date:  1987-10       Impact factor: 6.384

Review 6.  Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.

Authors:  J B Beckwith; N B Kiviat; J F Bonadio
Journal:  Pediatr Pathol       Date:  1990

7.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.

Authors:  M Gessler; A Poustka; W Cavenee; R L Neve; S H Orkin; G A Bruns
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

8.  Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.

Authors:  T P Fleming; T Matsui; M A Heidaran; C J Molloy; J Artrip; S A Aaronson
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

9.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

Authors:  I A Drummond; S L Madden; P Rohwer-Nutter; G I Bell; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

10.  Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.

Authors:  W A Bickmore; K Oghene; M H Little; A Seawright; V van Heyningen; N D Hastie
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

View more
  53 in total

Review 1.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 2.  Wilms' tumor gene WT1: its oncogenic function and clinical application.

Authors:  H Sugiyama
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.

Authors:  Y Ye; B Raychaudhuri; A Gurney; C E Campbell; B R Williams
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

4.  The Wilms tumor protein is persistently associated with the nuclear matrix throughout the cell cycle.

Authors:  Y Dobashi; T Kudoh; T Ishidate; M Shoji; K Toyoshima; T Akiyama
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

5.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

6.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

7.  NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter.

Authors:  Louise A Rafty; Fernando S Santiago; Levon M Khachigian
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

8.  Expression and function of the leucine zipper protein Par-4 in apoptosis.

Authors:  S F Sells; S S Han; S Muthukkumar; N Maddiwar; R Johnstone; E Boghaert; D Gillis; G Liu; P Nair; S Monnig; P Collini; M P Mattson; V P Sukhatme; S G Zimmer; D P Wood; J W McRoberts; Y Shi; V M Rangnekar
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

9.  Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions.

Authors:  E Wilson; K Sudhir; H E Ives
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Authors:  A Mishra; A K Ormerod; M L Cibull; B T Spear; S D Kraner; D M Kaetzel
Journal:  Cancer Gene Ther       Date:  2008-11-07       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.